From each FDA label

Do GLP-1s cause dizziness?

Dizziness is in the main trial table of 3 labels. The highest rate printed is 8% on Wegovy 2.4 mg (4% on placebo) and the lowest 4% on Zepbound 15 mg (2% on placebo). Separate trials, so not a ranking. Rybelsus/Ozempic tablets and Victoza list it only among reports after approval, without a rate.

Read from each manufacturer's FDA label on DailyMed. The newest revision saying anything on this is Jul 29, 2026.

Rate against placebo

How often dizziness happened in each medicine's trials

At the highest dose in each label's main table. Separate trials with different people, so compare each rate with its own placebo group, not with another medicine.

MedicineDoseOn itOn placeboDifferenceLabel
Wegovy2.4 mg8%4%+4 pointsDailyMed
Saxenda3 mg6.9%5%+1.9 pointsDailyMed
Zepbound15 mg4%2%+2 pointsDailyMed
Word for word

What each label says about dizziness

Sentences from each label's warnings and side effect sections. Only cross-references are removed.

Ozempic

  • Other adverse reactions with a frequency of >0.4% were associated with Ozempic include fatigue, dysgeusia and dizziness.

Label revised Jun 1, 2026. DailyMed

Foundayo

  • In a pool of Trials 1 and 2, dizziness was reported in 4% of Foundayo-treated patients and 3% of placebo-treated patients.

Label revised Jul 29, 2026. DailyMed

Saxenda

  • Events of asthenia, fatigue, malaise, dysgeusia and dizziness were mainly reported within the first 12 weeks of treatment with Saxenda and were often co-reported with gastrointestinal events such as nausea, vomiting, and diarrhea.

Label revised Feb 25, 2026. DailyMed

Byetta

  • Adverse reactions reported in ≥1.0% to <2.0% of patients receiving Byetta and reported more frequently than with placebo included decreased appetite, diarrhea, and dizziness.

Label revised Sep 2, 2025. DailyMed

Rybelsus and Ozempic tablets, Victoza: listed only among reports after approval, which come with no rate because nobody knows how many people took the medicine. Wegovy, Zepbound, Mounjaro, Trulicity: no finding on this in the sections read here.

Not from trials

Reports to FDA about dizziness

Counts of voluntary reports from patients and doctors. They cannot show that a medicine caused anything and cannot give a rate, and a brand used by more people draws more reports.

MedicineReports namingAll reports on it
ByettaDizziness: 2,67652,087
OzempicDizziness: 2,43670,863
MounjaroDizziness: 1,95197,440
TrulicityDizziness: 1,83587,279
ZepboundDizziness: 1,54580,835
VictozaDizziness: 1,28041,462
WegovyDizziness: 81825,993
Rybelsus and Ozempic tabletsDizziness: 3067,758
SaxendaDizziness: 2327,270
FoundayoDizziness: 1303,050

Counted through openFDA from FDA's Adverse Event Reporting System, refreshed weekly. One report can name several terms.

Updated automatically

Latest FDA label updates

Written from each source's own record as it changes. Every change on GLPcompare

Questions

Dizziness on a GLP-1: common questions

Which GLP-1 causes the most dizziness?

No trial here ranks them. By the rates each label prints, Wegovy 2.4 mg is highest at 8% (placebo 4%) and Zepbound 15 mg lowest at 4% (placebo 2%). These come from separate trials with different people and doses, so compare each to its own placebo group.

Does Wegovy cause dizziness?

In its FDA label, 8% of people taking Wegovy 2.4 mg reported dizziness, against 4% on placebo.

Does Saxenda cause dizziness?

In its FDA label, 6.9% of people taking Saxenda 3 mg reported dizziness, against 5% on placebo.

Does Zepbound cause dizziness?

In its FDA label, 4% of people taking Zepbound 15 mg reported dizziness, against 2% on placebo.

Other side effects

Trial rates describe groups, not what one person will feel. Talk to your clinician before starting, stopping or changing a medicine.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.